Leading Justice is a full-service marketing company working with law firms on a cash buy basis to sign up fully-qualified, fraud-free IVC filter cases. Here at Leading Justice, we can customize your firm’s IVC filter advertising needs and help you sign up cases via internal cash buys. Our clients only pay an agency fee to cover the cost of IVC filter advertising, plus a fee for each case we sign, and any data we generate for your firm belongs to you. We also cross-qualify all of our contacts, so any data we generate that isn’t eligible for the target campaign is reviewed to find out if it qualifies for another type of claim. By using innovative approaches to target contacts specifically related to IVC filters and side effects like filter fracture and migration, Leading Justice will increase your firm’s IVC filter case load. If you are interested in helping victims of alleged IVC filter complications, our extensive consumer reach and direct advertising strategies at Leading Justice give you the competitive edge and confidence you need to allocate your full budget, knowing that your money is being spent the best way possible.
Each and every law firm we work with at Leading Justice plays an important role in how we classify claims as qualified or not. While our experience working with plaintiff law firms allows us to recognize a great case when we see one, we will customize our IVC filter case intake specifications to the exact criteria you are seeking. So, if your firm has specific IVC filter qualifying case criteria you would like us to use, we can train our intake specialists to apply the criteria to each phone call and email they receive. By getting rid of the middle man, Leading Justice offers clients an opportunity for internal cash buys of IVC filter data with no chance of fraud.
IVC Filter Side Effect Litigation
IVC filters, also known as inferior vena cava filters, blood clot filters or vena cava filters, are small cone-shaped devices implanted in the inferior vena cava (the largest vein in the body) to trap blood clots and prevent them from traveling to the heart or lungs and causing pulmonary embolism or other complications. However, serious doubts have been raised recently about the safety and efficacy of IVC filters, in light of new research linking the medical devices to side effects like filter fracture, filter migration, perforation of the inferior vena cava, chronic chest pain, and damage to the heart or lungs. There are all different types of IVC filters manufactured by companies like C.R. Bard, Cook Medical and B. Braun Medical, and as more information is uncovered regarding the alleged risk of side effects from IVC filters, a growing number of product liability claims are expected to be filed against these companies in the coming months.
According to a drug safety communication issued by the FDA in August 2010, the agency received reports of more than 900 adverse events associated with IVC filters over the five-year period beginning in 2005, including 328 cases where the filter migrated to other parts of the body, 146 cases where broken fragments of the filter traveled through the bloodstream, 70 cases of inferior vena cava perforation, and 56 instances of the filter fracturing. In 2014, the FDA issued another drug safety communication, this time recommending that IVC filters be retrieved within 29-54 days after implantation, as long as the risk of pulmonary embolism has subsided at that time. Even patients who undergo surgery to have their IVC filter removed though, may suffer serious complications possibly resulting in permanent injury and the need for long-term medical care.